Human immunodeficiency virus (HIV) research hub
4 indexed studies · 1 currently recruiting
- ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3b, multicenter, single-arm, open-label study evaluating the efficacy, safety, and tolerability of switching to DTG/3TC single tablet regimen administered once daily from a bictegravir/emtricitabine/tenofovir alafenamide single tablet regimen in people living with HIV of at least 50 years of age who are virologically suppressed
This study is looking at an HIV medication called Dovato. It's for people aged 50 or older who are already stable on another HIV medicine, Biktarvy. Researchers want to see if switching to Dovato is safe, works well, and is easy to take.
Belgium · Italy · Portugal - recruitingPHASE3
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
This study is testing a new monthly tablet, MK-8527, to see if it can prevent HIV as effectively as current daily medicine. Researchers want to check its safety and how well people tolerate it, hoping to offer a convenient new way to protect against HIV.
United States · Argentina · Brazil - authorisedHuman Pharmacology (Phase I)- Other
Mass Balance and Absolute Oral Bioavailability of [14C]VH4524184
This early-stage study is looking at a new medicine called VH4524184 for people with HIV. It checks how the body takes in, uses, and gets rid of the medicine to understand it better. This helps scientists develop safer and more effective treatments for HIV.
Netherlands - ongoing, recruitingHuman Pharmacology (Phase I)- First administration to humans
A phase 1 Clinical Trial to Evaluate Safety and Immunogenecity of HIV SOSIP v8.2 763 Vaccine in healthy individuals
This study is testing a new possible vaccine for HIV. It's the very first time this vaccine is being given to people. Researchers want to see if it's safe and if it helps the body create a protective response against the virus.
Spain